Skip to main content
Caplight Logo









Bichedam Co., Ltd.

Bichedam Co., Ltd.

Private
South KoreaHealthcare & Life Scienceshttps://bichedam.co.kr/

Last Round

Pre Seed

Sep 17, 2025

Total Funding Raised

$2.02M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Bichedam Co., Ltd. is a biotechnology company that develops natural, herbal-based pharmaceutical treatments for aging-related vascular diseases, including hypertension and nocturnal leg cramps.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2C

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologyherbal medicinetraditional korean medicineTKMdrug developmentnatural therapeuticsnocturnal leg crampsvascular healthROCK inhibitorhealth supplementgeriatric careclinical trialsnutraceuticalsGMP manufacturingpharma R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bichedam Co., Ltd. Comparables

Compare Bichedam Co., Ltd. with similar companies based on industry and business-model similarity.

Bichedam Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PharmacoBio INC.
76%
MThera Pharma
74%
Hanpoong Pharm & Foods Co., Ltd.
69%

Bichedam Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedSep 17, 2025
GrantAug 22, 2024
SeedAug 22, 2024

Bichedam Co., Ltd. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 17, 2025

    $1.29M round with participation from K-Tech Finance.

  • Aug 22, 2024

    $362K raised from Daegyeong Regional University Joint Technology Holdings and others.

Bichedam Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Bichedam Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Bichedam Co., Ltd.'s valuation, stock price, and market status.

Is Bichedam Co., Ltd. a public or private company?

Bichedam Co., Ltd. is a private company.

What is the current stock price of Bichedam Co., Ltd.?

Bichedam Co., Ltd. is a private company with no public stock price. Caplight tracks Bichedam Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Bichedam Co., Ltd. worth (valuation)?

Valuation information for Bichedam Co., Ltd. is not publicly available.

Can I buy Bichedam Co., Ltd. stock?

Bichedam Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Bichedam Co., Ltd.'s last funding round?

Bichedam Co., Ltd.'s most recent funding round was Pre Seed on September 17, 2025.

Who are the main investors in Bichedam Co., Ltd.?

Key investors in Bichedam Co., Ltd. include Y&Archer, Gyeongbuk Center for Creative Economy & Innovation, The Next Lab, Agricultural Policy Insurance & Finance Service, Government of South Korea.

Will Bichedam Co., Ltd. IPO soon?

No public IPO plans have been announced for Bichedam Co., Ltd..

How can I track Bichedam Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Bichedam Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSouth Korea
Year Founded2022
Last FundingSep 17, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?